Learn how to make a simple power file DIY in this step-by-step tutorial. Whether you're new to DIY projects or a seasoned creator, this video guides you through the entire process, providing clear ...

Snapchat is launching a new Lens that lets users create and edit images using a text-to-image AI generator, the company told TechCrunch exclusively. The new “Imagine Lens” is available to Snapchat+ ...

BAY CITY, MI – A veteran-owned investment casting foundry in Bay City is poised for a major expansion, pending approval from the Bay City Commission. The commission will vote Monday, Sept. 8, on ...

Since late 2022, Honduras Próspera Inc. (HPI), a Delaware-based developer of a semi-autonomous zone on a Honduran island, has been locked in a nearly $11 billion legal battle with the Honduran ...

The Appellate Division, First Department, in an August decision, gutted financial penalties leveled against President Donald Trump and his companies, while finding him liable for repeated and ...

A Pennsylvania Representative is looking to allow for the creation of a Smokey Bear license plate. 9.4.25 Trailer full of guns and ammo bound for Mexico stopped at border Epstein Files Drop Shake Up ...

Assembly Member Micah Lasher, widely seen as the heir apparent to retiring Rep. Jerry Nadler, took the first step to run for Congress on Thursday morning when he filed with the Federal Election ...

WASHINGTON – The Republican-controlled House of Representatives voted on party lines on Aug. 3 to create a special panel to reinvestigate the events of the Jan. 6, 2021 insurrection. In 2022, after 18 ...

FedEx Corp. has launched a regional office in Riyadh and secured a Saudi economic license to operate as a foreign air carrier, deepening its bet on the kingdom as a rising logistics power in the ...

The endless offseason for the Rangers is coming to an end. Next week, rookie camp commences ahead of the traditional two games against the Flyers freshmen in Allentown, Pa., and the following week, ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.